查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户
市场调查报告书
商品编码
1562193

北美 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户

North America PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 140 Pages | 订单完成后即时交付

价格

北美PCR技术市场预计将从2022年的50.7581亿美元成长到2030年的96.3486亿美元。

PCR 技术的进步推动北美 PCR 技术市场

PCR 的优点，例如灵敏度高、相对简单性和成本效益高，在过去几年中大大增加了它的受欢迎程度。 PCR 技术已经发生了显着的发展，为各种应用带来了更具体的工作流程。 PCR 技术正在探索多种非常规应用，使分子诊断变得更容易、更快捷。 dPCR 和 RT-PCR 的进步可用于诊断疾病、识别病毒和细菌以及协助法医调查。研究人员正在尝试使用一些奈米材料来减少测试时间。 2023 年 3 月，韩国科学技术研究院 (KIST) 智慧感测增强安全系统中心宣布开发出超快速 PCR 技术。该开发案由 Sang Kyung Kim 博士（董事）和 Seungwon Jung 博士的研究团队领导。与先前利用光热奈米材料进行的测试相比，超快速PCR将测试时间缩短了10倍。新方法的诊断效能与现有测试方法相当，并且可以在5分钟内完成。 2021 年 1 月，丹纳赫公司宣布加拿大卫生部向 Cepheid 颁发了用于 Xpert Xpress SARS-CoV-2/Flu/RSV 的医疗器材许可证。 PCR 技术市场中该公司的一些技术进步如下：2021 年 3 月，PCR Biosystems 宣布推出其 IsoFast Bst 聚合酶试剂，该试剂支援灵敏、稳健和快速的 RNA 和 DNA 扩增，从而实现更快的测试程序。 2021 年 10 月，Thermo Fisher Scientific 推出了 Applied Biosystem Quantstudio Absolute Q-Digital PCR 系统，这是第一个完全整合的 dPCR 系统，旨在提供高度准确且一致的遗传分析。该公司声称该产品可在 90 分钟内产生研究结果。 2022 年 5 月，Bio-Rad Laboratories, Inc. 在接受 CE 标誌的选定国家推出了 CFX Duet 即时 PCR 系统。该系统旨在支持研究人员开发单重和双重 qPCR 检测。 2022年11月，PCR Biosystems推出了新的qPCR试剂混合物－Clara Probe Mix、Clara Probe 1-Step Mix和Clara HRM Mix。 2022年11月，Cepheid推出了Xpert Xpress MVP多重PCR测试。此测试有助于从单一样本中检测与三种不同病症（即细菌性阴道炎(BV)、滴虫病和外阴阴道念珠菌病）相关的生物体DNA，从而有助于更精确的诊断并支持准确的抗生素治疗方案。因此，这些进步预计将在未来几年为 PCR 技术市场带来新趋势。

北美 PCR 技术市场概况

北美 PCR 技术市场分为美国、加拿大和墨西哥。该地区的市场成长归因于生物分析仪器製造商和 PCR 公司对创新产品的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。此外，在医疗保健操作中采用医疗设备来提高品质和降低成本的众所周知的做法也有利于美国和其他北美国家的 PCR 技术市场。研究和治疗中对 CRISPR 和 PCR 等基因合成和编辑工具的接受和采用激增，需要有助于快速定量、改变和观察的检测。液滴数位 PCR 形式的数位 PCR 的出现为筛选提供了新的机会，具有卓越的灵敏度和简单的适应性。美国正在寻求公共和私人组织的大量资金，以鼓励对先进研究方法的投资。例如，国际基因工程和生物技术中心旨在促进成员国之间的合作研究。它透过合作研究计划（CRP）获得资金，该计划旨在解决相关和有趣的原始科学问题。生物技术的进步依赖 PCR 技术来帮助改善人类健康、动物福利和粮食安全。美国食品药物管理局（USFDA）致力于确保生物技术产品的安全。美国积极参与各种研究团体和组织举办的科学会议、研讨会和活动，帮助交流不同地区内基于PCR的趋势和最新研究成果。因此，国家的积极参与也是推动PCR技术市场成长的因素之一。

北美 PCR 技术市场收入及 2030 年预测（百万美元）

北美 PCR 技术市场细分

北美 PCR 技术市场分为技术、产品、应用、最终用户和国家。

根据技术，北美 PCR 技术市场分为即时 PCR、常规 PCR、逆转录、数位 PCR、多重 RTPCR、热启动 PCR 等。 2022 年，即时 PCR 领域占据北美 PCR 技术市场的最大份额。

就产品而言，北美 PCR 技术市场分为试剂和耗材、仪器以及软体和服务。到2022年，试剂和耗材细分市场在北美PCR技术市场中占据最大份额。此外，西林瓶尺寸分为0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，仪器部分分为桌上型 PCR 和便携式热循环仪/PCR。

依应用划分，北美 PCR 技术市场分为基因表现分析、基因定序、基因分型、核酸合成、标准验证、护理点诊断应用、环境应用等。 2022 年，基因表现分析领域占据北美 PCR 技术市场的最大份额。

根据最终用户，北美 PCR 技术市场分为医院和诊断中心、製药和生物技术公司、学术机构和研究实验室等。 2022 年，医院和诊断中心领域占据北美 PCR 技术市场的最大份额。

依国家划分，北美 PCR 技术市场分为美国、加拿大和墨西哥。 2022 年，美国将主导北美 PCR 技术市场。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Atila Biosystems Inc、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc、Visby Medical Inc 和Ellume Ltd 是北美PCR 技术市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美 PCR 技术市场 - 主要产业动态

  • PCR 技术市场 - 主要产业动态
  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
    • PCR 技术的投资和资金供应激增
  • 市场限制
    • PCR 系统的高成本和替代检测的可用性
  • 市场机会
    • POC 测试需求不断增加
  • 未来趋势
    • PCR 技术的进步
  • 驱动因素和限制的影响：

第 5 章：PCR 技术市场 - 北美市场分析

  • PCR 技术市场收入，2020 - 2030

第 6 章：北美 PCR 技术市场分析 - 按技术

  • 概述
  • 实时萤光定量PCR
  • 常规PCR
  • 逆转录聚合酶连锁反应
  • 数位PCR
  • 多重逆转录聚合酶连锁反应
  • 热启动PCR
  • 其他的

第 7 章：北美 PCR 技术市场分析 - 按产品

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按产品划分）（%）
  • 试剂及耗材
  • 仪器仪表
  • 软体和服务

第 8 章：北美 PCR 技术市场分析 - 按应用

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额，按应用划分 (%)
  • 基因表现分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 标准验证
  • 护理点诊断
  • 环境应用
  • 其他的

第 9 章：北美 PCR 技术市场分析 - 按最终用户

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 学术界及研究机构
  • 製药和生物技术公司
  • 其他的

第 10 章：北美 PCR 技术市场 - 国家分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

第 11 章：PCR 技术市场-产业格局

  • 概述
  • PCR 技术市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Atila Biosystems Inc
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Visby Medical Inc
  • Ellume Ltd

第 13 章：附录

Product Code: BMIRE00030517

The North America PCR technologies market is expected to grow from US$ 5,075.81 million in 2022 to US$ 9,634.86 million by 2030. It is estimated to record a CAGR of 8.3%from 2022 to 2030.

Advancements in PCR Technologies Fuel North America PCR Technologies Market

The advantages of PCR such as exquisite sensitivity, relative simplicity, and cost-effectiveness have tremendously added to its popularity in the past years. The PCR technology has evolved significantly, resulting in more specific workflows for a wide variety of applications. The use of PCR technology is being explored into several nonconventional applications, making molecular diagnosis easier and faster. Advancements in dPCR and RT-PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST) announced the development of an ultrafast PCR technology. The development project was led by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung's research team. The ultrafast PCR reduces the test duration by 10 times compared to the previous tests by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to existing test methods, and it can be finished in 5 minutes. In January 2021, Danaher Corporation announced that Health Canada issued a medical device license to Cepheid for Xpert Xpress SARS-CoV-2/Flu/RSV. A few of the technological advancements by companies in the PCR technologies market are as given, In March 2021, PCR Biosystems announced the launch of its IsoFast Bst polymerase reagents, which support sensitive, robust, and rapid amplification of RNA and DNA, enabling faster testing procedures. In October 2021, Thermo Fisher Scientific introduced the Applied Biosystem Quantstudio Absolute Q-Digital PCR System, the first fully integrated dPCR system designed to deliver highly accurate and consistent genetic analysis. The company claims that the product generates research results within 90 minutes. In May 2022, Bio-Rad Laboratories, Inc. introduced its CFX Duet Real-Time PCR System in selected countries that accept the CE Mark. The system is intended to support researchers in developing singleplex and duplex qPCR assays. In November 2022, PCR Biosystems launched new qPCR reagent mixes-Clara Probe Mix, Clara Probe 1-Step Mix, and Clara HRM Mix. In November 2022, Cepheid launched the Xpert Xpress MVP multiplex PCR test. The test helps detect DNA from organisms that are associated with three distinct conditions, namely, bacterial vaginosis (BV), trichomoniasis, and vulvovaginal candidiasis, from a single sample, aiding in more precise diagnosis and supporting accurate antibiotic treatment regimens. Thus, such advancements are expected to bring new trends into the PCR technologies market in the coming years.

North America PCR Technologies Market Overview

The North America PCR technologies market is segmented into the US, Canada, and Mexico. Market growth in this region is attributed to the increased demand for innovative products from bioanalytical instrument manufacturers and PCR companies, the presence of key market players, and extensive R&D conducted across various academic and research institutes. In addition, the well-known practice of adopting medical devices in healthcare operations to improve quality and reduce costs also benefits the PCR technologies market in the US and other North American countries. An upsurge in the acceptance and adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that aid in rapid quantification, alterations, and observation. The emergence of digital PCR in the form of droplet digital PCR offers new opportunities for screening, providing superior sensitivity and easy adaptability. The US is seeking significant funding from public and private organizations to encourage investments in advanced research methodologies. For instance, the International Centre for Genetic Engineering and Biotechnology aims to stimulate collaborative research in the member states. It receives funds through the Collaborative Research Programme (CRP) that aims to address original scientific problems of relevance and interest. Advancements in biotechnology that depend on PCR techniques to help improve human health, animal welfare, and food security. The US Food and Drug Administration (USFDA) is committed to ensuring the safety of biotechnology products. The US actively participates in various research groups and organizations to conduct scientific conferences, workshops, and events that help exchange the trends and latest research studies based on PCR within different geographies. Therefore, the country's active involvement is also one of the factors driving the growth of the PCR technologies market.

North America PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

North America PCR Technologies Market Segmentation

The North America PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the North America PCR technologies market is segmented into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of North America PCR technologies market in 2022.

In terms of offerings, the North America PCR technologies market is categorized into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of North America PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR and portable thermocyclers/PCR.

By application, the North America PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of North America PCR technologies market in 2022.

Based on end user, the North America PCR technologies market is categorized into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of North America PCR technologies market in 2022.

By country, the North America PCR technologies market has been categorized into the US, Canada, and Mexico. The US dominated the North America PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Atila Biosystems Inc, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, Visby Medical Inc, and Ellume Ltd are some of the leading companies operating in the North America PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - North America Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. North America PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. North America PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. North America PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. North America PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. North America PCR Technologies Market - Country Analysis

  • 10.1 North America: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 North America PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 United States
        • 10.1.2.1.1 Overview
      • 10.1.2.2 United States PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 United States PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 United States PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 United States PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 United States PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 United States PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 United States PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 United States PCR Technologies Market Breakdown by End User
      • 10.1.2.3 Canada
        • 10.1.2.3.1 Overview
      • 10.1.2.4 Canada PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 Canada PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 Canada PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 Canada PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 Canada PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 Canada PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 Canada PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 Canada PCR Technologies Market Breakdown by End User
      • 10.1.2.5 Mexico
        • 10.1.2.5.1 Overview
      • 10.1.2.6 Mexico PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 Mexico PCR Technologies Market Breakdown by Technology
        • 10.1.2.6.2 Mexico PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.2.1 Mexico PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.2.2 Mexico PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.2.2.1 Mexico PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.3 Mexico PCR Technologies Market Breakdown by Application
        • 10.1.2.6.4 Mexico PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Atila Biosystems Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Takara Bio Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Standard Biotools Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Agilent Technologies Inc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Visby Medical Inc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Ellume Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 31. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 32. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. North America: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. North America PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. United States PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. Canada PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. Mexico PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Growth Strategies in the PCR Technologies Market